Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Employment agrmnt
Quarterly results
Director comp.
MoonLake Immunotherapeutics Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 4 Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Bought 58,839 shares @ $59.8973, valued at $3.5M
10/04/2023 4 Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Bought 74,911 shares @ $57.37, valued at $4.3M
Bought 150,487 shares @ $57.252, valued at $8.6M
Bought 67,814 shares @ $57.3188, valued at $3.9M
10/03/2023 4 Sturge Simon (Director) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Converted 342,980 shares @ $0
Disposed/sold 342,980 shares @ $0
Converted 10,196 options to buy @ $0
10/03/2023 4 Bodenstedt Matthias (CFO) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Converted 62,972 shares @ $0
Disposed/sold 62,972 shares @ $0
Converted 1,872 options to buy @ $0
10/03/2023 4 Santos da Silva Jorge (CEO) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Converted 3,027,483 shares @ $0
Disposed/sold 3,027,483 shares @ $0
Converted 140,071 shares @ $0
Disposed/sold 140,071 shares @ $0
Converted 90,000 options to buy @ $0
Converted 4,164 options to buy @ $0
10/03/2023 4 Reich Kristian (Chief Scientific Officer) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Converted 2,527,477 shares @ $0
Disposed/sold 2,527,477 shares @ $0
Converted 41,981 shares @ $0
Disposed/sold 41,981 shares @ $0
Converted 75,136 options to buy @ $0
Converted 1,248 options to buy @ $0
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "MoonLake Immunotherapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update"
07/05/2023 4 Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Bought 800,000 shares @ $50, valued at $40M
06/30/2023 SC 13D/A BIOTECHNOLOGY VALUE FUND L P reports a 35.8% stake in MoonLake Immunotherapeutics
06/29/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "MOONLAKE IMMUNOTHERAPEUTICS"
06/29/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
06/28/2023 4 Chen Bihua (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Bought 1,481 shares @ $36.91, valued at $54.7k
Bought 3,755 shares @ $38.18, valued at $143.4k
Bought 10,593 shares @ $39.17, valued at $414.9k
Bought 38,623 shares @ $39.87, valued at $1.5M
Bought 50,642 shares @ $41.03, valued at $2.1M
Bought 61,042 shares @ $42.12, valued at $2.6M
Bought 66,087 shares @ $43.3, valued at $2.9M
Bought 31,558 shares @ $44.23, valued at $1.4M
Bought 10,946 shares @ $44.93, valued at $491.8k
Bought 37,783 shares @ $48.93, valued at $1.8M
Bought 59,787 shares @ $49.82, valued at $3M
06/12/2023 4 BVF PARTNERS L P/IL (10% Owner) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Granted 11,297 options to buy @ $29.18, valued at $329.6k
06/12/2023 4 Sturge Simon (Director) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Granted 11,297 options to buy @ $29.18, valued at $329.6k
06/12/2023 4 Xavier Ramnik (Director) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Granted 11,297 options to buy @ $29.18, valued at $329.6k
06/12/2023 4 Loy Spike (Director) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Granted 11,297 options to buy @ $29.18, valued at $329.6k
06/12/2023 4 Moukheibir Catherine (Director) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Granted 11,297 options to buy @ $29.18, valued at $329.6k
06/12/2023 4 Phillips Andrew John (Director) has filed a Form 4 on MoonLake Immunotherapeutics
Txns: Granted 11,297 options to buy @ $29.18, valued at $329.6k
06/07/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/19/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/11/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/10/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/05/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/01/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
05/01/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
04/26/2023 ARS Form ARS - Annual Report to Security Holders:
04/26/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/26/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/19/2023 8-K Quarterly results
03/31/2023 SC 13G Chen Bihua reports a 17.6% stake in MoonLake Immunotherapeutics
03/28/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
03/28/2023 EFFECT Form EFFECT - Notice of Effectiveness:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy